glp 1 anti obesity Glucagon-Like Peptide-1 Based Therapies: A New Horizon in Management GLP-1 drugs are reshaping obesity

HbA1c measures the average blood sugar levels over the past three months, corresponding to the average lifespan of red blood cells (RBCs) and indicating the extent to which the RBCs are "sugar-coated." For reference, the American Diabetes Association (ADA) advises that the target A1C for most adults with diabetes should be below 7%

The impact of their molecular mechanisms has been evidenced by landmark trials, which have repeatedly demonstrated that certain GLP-1 RAsincluding liraglutide, semaglutide, and dulaglutideare particularly efficacious in reducing MACE, especially in patients with established ASCVD

In the STEP-4 trial, 902 participants received semaglutide 2.4 mg for the initial 20 weeks, and were then randomly assigned to receive either (a) semaglutide or (b) a placebo for the remaining 48 weeks (4)

Caution notes Magnesium can cause loose stools in some people, especially citrate